Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
6
Bearish filings
35
Named actors
17
Disclosed $ (bull / bear)
$20K + 5 of unknown size / $43.7M + 6 of unknown size
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-09-21 | 5%+ holder (13G) BIOTECHNOLOGY VALUE FUND L P | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-09-17 | 5%+ holder (13G) Paradigm Biocapital Advisors LP | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-09-15 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2026-09-09 | Director Verjee Rehan | bought | $20K | SEC ↗ |
| 2026-08-04 | President, Chief Executive Officer and Director Todd Harris | adopted a selling plan | — | SEC ↗ |
16 more disclosures in the window — the full record, scoring, and track-record evidence are for members.
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-08-04 | Chief Operating Officer Bhavesh Ashar | adopted a selling plan | — | SEC ↗ |
| 2026-08-04 | Chief Financial Officer Alan Fuhrman | adopted a selling plan | — | SEC ↗ |
| 2026-08-04 | Vice President, Finance (principal accounting officer) Julia Rueb | adopted a selling plan | — | SEC ↗ |
| 2026-08-04 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2026-06-26 | Shareholder (via Merrill Lynch) NEXTECH VI ONCOLOGY SCSP | filed notice to sell | $9.5M | SEC ↗ |
| 2026-06-01 | Shareholder (via Merrill Lynch) NEXTECH VI ONCOLOGY SCSP | filed notice to sell | $10.0M | SEC ↗ |
| 2026-05-12 | Officer (via Merrill Lynch) Daniel Bensen | filed notice to sell | $274K | SEC ↗ |
| 2026-04-13 | Officer (via Merrill Lynch) Daniel Bensen | filed notice to sell | $285K | SEC ↗ |
| 2026-04-07 | 5%+ holder (13G) FMR LLC | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-03-26 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) GILLA KAPLAN | filed notice to sell | $2.0M | SEC ↗ |
| 2026-03-25 | Director KAPLAN GILLA | sold | $528K | SEC ↗ |
| 2026-03-25 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) GILLA KAPLAN | filed notice to sell | $529K | SEC ↗ |
| 2026-03-12 | Officer (via Merrill Lynch) Daniel Bensen | filed notice to sell | $283K | SEC ↗ |
| 2026-02-20 | 5%+ holder (13G) Farallon Capital Partners, L.P. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-02-13 | 5%+ holder (13G) Harris Todd | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-02-12 | Chief Discovery Officer Bensen Daniel | sold | $67K | SEC ↗ |
| 2026-02-12 | Chief Discovery Officer Bensen Daniel | sold | $196K | SEC ↗ |
| 2026-02-12 | Officer (via Merrill Lynch) Daniel Bensen | filed notice to sell | $262K | SEC ↗ |
| 2026-01-12 | Chief Discovery Officer Bensen Daniel | sold | $199K | SEC ↗ |
| 2026-01-12 | Chief Discovery Officer Bensen Daniel | sold | $30K | SEC ↗ |